お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
962212

心臓モニタリング (CM )および心調律管理 (CRM) デバイスの世界市場 (~2025年):タイプ (ECG (ホルターモニター)・ILR・イベントモニター ・除細動器・AED・ペースメーカー (CRT P・デュアルチャンバー型))・エンドユーザー・地域別

Cardiac Monitoring & Cardiac Rhythm Management Devices Market By Product CM (ECG (Holter Monitor), ILR, Event Monitor)), CRM ((Defibrillator (ICD) External (AED)), Pacemaker (CRT P, Dual Chamber Pacemaker)), End User - Global Forecast to 2025

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 254 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=104.84円
心臓モニタリング (CM )および心調律管理 (CRM) デバイスの世界市場 (~2025年):タイプ (ECG (ホルターモニター)・ILR・イベントモニター ・除細動器・AED・ペースメーカー (CRT P・デュアルチャンバー型))・エンドユーザー・地域別
出版日: 2020年09月23日
発行: MarketsandMarkets
ページ情報: 英文 254 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の心臓モニタリング (CM )および心調律管理 (CRM) デバイスの市場規模は予測期間中4.0%のCAGRで推移し、2020年の221億米ドルから、2025年には268億米ドルの規模に成長すると予測されています。

心血管疾患の有病率の拡大、CMおよびCRMデバイスの償還のアベイラビリティ、参入事業者による革新的製品の発売、デバイス研究抜向けた投資、ファンド、助成金の増加、ウェアラブル心臓デバイスが好まれる傾向などの要因が同市場の成長を推進しています。また、植込み型心臓電気デバイス (CIED) による感染予防対策が予測期間中に成長機会を示す見通しです。

当レポートでは、世界の心臓モニタリング (CM )および心調律管理 (CRM) デバイスの市場を調査し、市場の定義と概要、バリューチェーン、新型コロナウイルス感染症 (COVID-19) およびその他の市場影響因子の分析、市場規模の推移・予測、タイプ・エンドユーザー・地域/主要国など各種区分別の内訳、競合環境、主要企業のプロファイルなどをまとめています。

962212_4.3 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET_GEOGRAPHIC GROWTH OPPORTUNITIES_FIGURE 13

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 制限
    • 課題
    • 市場機会
  • バリューチェーン分析
  • エコシステム分析
  • 平均販売価格

第6章 CMデバイス市場の分析・予測:タイプ別

  • イントロダクション
  • ECGデバイス
    • 安静時ECG
    • ストレスECG
    • ホルターモニター
  • 植込み型ループレコーダー
  • モバイル心臓テレメトリデバイス
  • 心拍出量モニタリングデバイス
  • イベントモニター
  • スマートECGモニター
  • COVID-19の影響分析

第7章 CRMデバイス市場の分析・予測:タイプ別

  • 除細動器
    • 植込み型
    • 外付け型
  • ペースメーカー
  • COVID-19の影響分析

第8章 市場分析・予測:エンドユーザー別

  • イントロダクション
  • 病院
  • 診療所・心臓センター・外来手術センター
  • その他
  • COVID-19の影響分析

第9章 市場分析・予測:地域別

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他
  • その他の地域

第10章 競合情勢

  • 概要
  • 競合シナリオ

第11章 企業の評価マトリックス・企業プロファイル

  • 企業評価マトリックス:定義・調査手法
  • 企業の評価マトリックス
  • 競合リーダーシップマッピング
  • 企業プロファイル
    • ABBOTT LABORATORIES
    • MEDTRONIC PLC
    • BOSTON SCIENTIFIC CORPORATION
    • GE HEALTHCARE
    • KONINKLIJKE PHILIPS NV
    • BIOTRONIK
    • ASAHI KASEI CORPORATION
    • MICROPORT SCIENTIFIC CORPORATION
    • HILL-ROM HOLDINGS, INC.
    • NIHON KOHDEN CORPORATION
    • SCHILLER AG
    • BIOTELEMETRY
    • ACS DIAGNOSTICS
    • BPL MEDICAL TECHNOLOGIES
    • BTL
    • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • LEPU MEDICAL TECHNOLOGY
    • SHREE PACETRONIX
    • OSYPKA AG
    • ALIVECOR, INC.
    • AMIITALIA
    • BEXEN CARDIO
    • NARANG MEDICAL LIMITED
    • METRAX GMBH
    • PROGETTI SRL

第12章 隣接市場

第13章 付録

目次
Product Code: MD 1038

The global cardiac monitoring & cardiac rhythm management devices market is projected to reach USD 26.8 billion by 2025 from USD 22.1 billion in 2020, at a CAGR of 4.0% from 2020 to 2025. The growth of this market is driven by the increasing prevalence of cardiovascular diseases; availability of reimbursement for CM & CRM devices; launch of innovative products by market players; increasing investments, funds, and grants for research on CM & CRM devices; and the growing preference for wearable cardiac devices. Also, measures to reduce infections caused due to CIEDs to offer an opportunity for the growth of the market during the forecast period.

"ECG devices is expected to hold the largest share of the cardiac monitoring devices market in 2020"

On the basis of cardiac monitoring devices by type, the market is segmented into ECG devices, event monitors, implantable loop recorders (ILRs), cardiac output monitoring (COM) devices, mobile cardiac telemetry (MCT) devices, and smart ECG monitors. In 2019, the ECG devices segment accounted for the largest share of the cardiac monitoring devices market. The large share of this segment can be attributed to technological advancements such as the incorporation of advanced algorithms and workflow improvement features, such as simplified operations, touchscreen systems, portability, wireless features, and better connectivity with cardiovascular information systems (CVIS), electronic medical records (EMRs), and ECG management systems.

"Defibrillators is expected to hold the largest share of the cardiac rhythm management devices market in 2020"

On the basis of cardiac rhythm management devices by type, the market is segmented into defibrillators and pacemakers. In 2019, the defibrillators segment accounted for the largest market share. This segment is also projected to register the highest CAGR during the forecast period. Factors such as technological advancements in defibrillators, rising prevalence of CVD, and growing focus on providing public-access defibrillators are driving the growth of this market.

"Hospitals segment commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020"

By end user, the cardiac monitoring & cardiac rhythm management devices market is segmented into hospitals; clinics, cardiac centers, and ambulatory surgery centers (ASCs); and other end users. Hospitals accounted for the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2019. The large share of this segment can be attributed to factors such as the increasing prevalence of CVD, the growing number of patient visits to hospitals for diagnosis, increasing number of cardiac implant procedures, and the availability of reimbursement for these procedures across developed markets.

"North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market in 2020."

On the basis of region, the cardiac monitoring & cardiac rhythm management devices market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America commanded the largest share of the cardiac monitoring & cardiac rhythm management devices market. The large share of this market segment can be attributed to the increasing incidence of CVD, increasing healthcare expenditure, growing disposable income, growing healthcare awareness, and the availability of technologically advanced devices in the region.

Breakdown of supply-side primary interviews, by company type, designation, and region:

  • By Company Type: Tier 1 (40%) , Tier 2 (30%), and Tier 3 (30%)
  • By Designation: C-level (27%), Director-level (18%), and Others (55%)
  • By Region: North America (50%), Europe (20%), AsiaPacific (15%), and RoW (15%).

The some of the major players operating in this market are: Abbott Laboratories (US), Medtronic (Ireland) and Boston Scientific Corporation (US).

List of Companies Profiled in the Report:

  • Medtronic (Ireland)
  • Boston Scientific Corporation (US)
  • Abbott Laboratories (US)
  • GE Healthcare (US)
  • BIOTRONIK (Germany)
  • Koninklijke Philips (Netherlands)
  • Asahi Kasei Corporation (Japan)
  • MicroPort Scientific Corporation (China)
  • Hill-Rom Holdings (US)
  • Nihon Kohden (Japan)
  • SCHILLER AG (Switzerland)
  • BioTelemetry (US)
  • BPL Medical Technologies (India)
  • ACS Diagnostics (US)
  • Shenzhen Mindray Bio-Medical Electronics (China)
  • Lepu Medical Technology (China)
  • Shree Pacetronix (India)
  • OSYPKA (Germany)
  • BTL (US)
  • Alivecor, Inc. (US)
  • Amiitalia (Italy)
  • Bexen Cardio (Spain)
  • Narang Medical Limited (India)
  • MeTrax GmbH (Germany)
  • Progetti Srl (Italy).

Research Coverage:

This report studies the cardiac monitoring & cardiac rhythm management devices market based on cardiac monitoring devices by type, cardiac rhythm management devices by type, end user, and region. The report also analyzes factors (such as drivers, restraints, challenges, and opportunities) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cardiac monitoring & cardiac rhythm management devices market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on cardiac monitoring & cardiac rhythm management devices offered by the top 25 players in the cardiac monitoring & cardiac rhythm management devices market. The report analyzes the cardiac monitoring & cardiac rhythm management devices market by cardiac monitoring devices by type, cardiac rhythm management devices by type, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devices across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cardiac monitoring & cardiac rhythm management devices market
  • Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the cardiac monitoring & cardiac rhythm management devices market

Frequently asked questions:

  • What are the growth opportunities in the cardiac monitoring & cardiac rhythm management devices market across major regions in the future?
  • Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
  • What are the various cardiac monitoring & cardiac rhythm management devices product types and their respective market shares in the overall market?
  • What are the new trends and advancements in the cardiac monitoring & cardiac rhythm management devices market?
  • What is the impact of COVID-19 on cardiac monitoring & cardiac rhythm management devices market?

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKET COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES
  • 1.8 LIMITATIONS OF THE CURRENT EDITION

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
  • 2.2 PRIMARY DATA
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
    • 2.3.1 BOTTOM-UP APPROACH
    • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH CRM DEVICES MARKET
    • 2.3.2 GROWTH FORECAST
    • 2.3.3 TOP-DOWN APPROACH
    • FIGURE 5 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 6 MARKET DATA TRIANGULATION METHODOLOGY
  • 2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

    • FIGURE 7 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 8 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
    • FIGURE 9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
    • FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET OVERVIEW
    • FIGURE 11 INCREASING INCIDENCE OF CARDIOVASCULAR DISEASES TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE AND COUNTRY (2019)
    • FIGURE 12 DEFIBRILLATORS SEGMENT ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2019
  • 4.3 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 13 CHINA TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 14 CM & CRM DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Rising prevalence of cardiovascular disease
    • FIGURE 15 INCIDENCE OF CVD, BY REGION, 2017
      • 5.2.1.2 Availability of reimbursement for CM & CRM devices
    • TABLE 1 CPT CODES FOR CM & CRM DEVICES, 2020
      • 5.2.1.3 Launch of innovative products by market players
    • TABLE 2 RECENT PRODUCT LAUNCHES IN THE CM & CRM DEVICES MARKET
      • 5.2.1.4 Increasing investments, funds, and grants for research on CM & CRM devices
      • 5.2.1.5 Growing preference for wearable cardiac devices
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Frequent product recalls
    • TABLE 3 KEY PRODUCT RECALLS
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Risk of associated cybersecurity vulnerabilities
      • 5.2.3.2 Stringent regulatory requirements delaying the approval of cardiac devices
      • 5.2.3.3 Dearth of skilled professionals with expertise in electrocardiography and cardiac rhythm management devices
    • 5.2.4 OPPORTUNITIES
      • 5.2.4.1 Measures to reduce infections caused due to CIEDs
  • 5.3 VALUE CHAIN ANALYSIS
    • FIGURE 16 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
    • FIGURE 17 DIRECT DISTRIBUTION-THE PREFERRED STRATEGY FOR PROMINENT COMPANIES
  • 5.4 ECOSYSTEM ANALYSIS
    • FIGURE 18 ECOSYSTEM ANALYSIS OF THE CARDIOVASCULAR DEVICES MARKET
  • 5.5 AVERAGE SELLING PRICE TREND
    • FIGURE 19 AVERAGE PRICE FOR ECG DEVICES, 2019 VS. 2022 VS. 2025 (USD/UNIT)
    • 5.5.1 COVID-19 IMPACT ON THE CM & CRM DEVICES MARKET

6 CARDIAC MONITORING DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 4 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 5 CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 6 ECG DEVICES & EVENT MONITORS MARKET, BY TYPE, 2018-2025 (UNITS)
  • 6.2 ECG DEVICES
    • TABLE 7 ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 8 ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 9 ECG DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 10 ECG DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 6.2.1 RESTING ECG DEVICES
      • 6.2.1.1 Low cost, ease of use, and simplicity have driven the adoption of resting ECG devices
    • TABLE 11 RESTING ECG DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 12 RESTING ECG DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 6.2.2 STRESS ECG DEVICES
      • 6.2.2.1 Their flexibility of use has driven the demand for stress ECG devices, but high cost has negatively affected the market
    • TABLE 13 STRESS ECG DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 14 STRESS ECG DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 6.2.3 HOLTER MONITORS
      • 6.2.3.1 Short duration of monitoring is a key restraint to market growth
    • TABLE 15 HOLTER MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 16 HOLTER MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 6.3 IMPLANTABLE LOOP RECORDERS
    • 6.3.1 HIGH COST AND LIMITED APPLICATIONS HAVE HINDERED DEMAND GROWTH
    • TABLE 17 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 18 IMPLANTABLE LOOP RECORDERS MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 6.4 MOBILE CARDIAC TELEMETRY DEVICES
    • 6.4.1 INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS IS PROPELLING MARKET GROWTH
    • TABLE 19 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 20 MOBILE CARDIAC TELEMETRY DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 6.5 CARDIAC OUTPUT MONITORING DEVICES
    • 6.5.1 INCREASING NUMBER OF CARDIAC SURGERIES WILL DRIVE THE DEMAND FOR COM DEVICES
    • TABLE 21 TYPES OF COM DEVICES
    • TABLE 22 CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 23 CARDIAC OUTPUT MONITORING DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 6.6 EVENT MONITORS
    • TABLE 24 EVENT MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 25 EVENT MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 6.6.1 EVENT MONITORS MARKET, BY TYPE
    • TABLE 26 EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 27 EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
      • 6.6.1.1 Pre-symptom event monitors
        • 6.6.1.1.1 Large storage capacity of pre-symptom event monitors makes them ideal for long-term monitoring
    • TABLE 28 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 29 PRE-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
      • 6.6.1.2 Post-symptom event monitors
        • 6.6.1.2.1 The emergence of handheld, wireless, and remote monitors will drive market growth
    • TABLE 30 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 31 POST-SYMPTOM EVENT MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 6.6.2 EVENT MONITORS MARKET, BY TECHNOLOGY
      • 6.6.2.1 Autodetect monitors
        • 6.6.2.1.1 Autodetect monitors are ideal for patients who are unable to trigger monitors reliably
      • 6.6.2.2 Manual event monitors
        • 6.6.2.2.1 Manual monitors can be pre-symptom or post-symptom, but rely on the patient to be triggered
  • 6.7 SMART ECG MONITORS
    • 6.7.1 LACK OF DATA SECURITY HINDERS THE GROWTH OF THE SMART MONITORS MARKET TO SOME EXTENT
    • TABLE 32 INDICATIVE LIST OF SMART ECG MONITORS
    • TABLE 33 SMART ECG MONITORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 34 SMART ECG MONITORS MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 6.8 COVID-19 IMPACT ANALYSIS

7 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 35 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 36 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 37 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2018-2025 (UNITS)
  • 7.2 DEFIBRILLATORS
    • TABLE 38 DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 39 DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 40 DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 41 DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 7.2.1 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
    • TABLE 42 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 43 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 44 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 45 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
      • 7.2.1.1 Transvenous implantable cardioverter defibrillators (T-ICDs)
    • TABLE 46 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 47 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 48 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 49 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
        • 7.2.1.1.1 Biventricular ICDS/CRT-Ds
        • 7.2.1.1.1.1 Biventricular ICDs/CRT-Ds are preferred for heart failure patients
    • TABLE 50 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 51 BIVENTRICULAR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
        • 7.2.1.1.2 Dual-chamber ICDs
        • 7.2.1.1.2.1 The benefits of dual-chamber ICDs, such as higher diagnostic accuracy, make them ideal for patients with tachycardia episodes
    • TABLE 52 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 53 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
        • 7.2.1.1.3 Single-chamber ICDs
        • 7.2.1.1.3.1 Launch of MRI-compatible single-chamber ICDs will drive market growth
    • TABLE 54 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 55 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
      • 7.2.1.2 Subcutaneous implantable cardioverter defibrillators
        • 7.2.1.2.1 Safety and efficacy of S-ICDs in the prevention of sudden cardiac arrest will boost their adoption
    • TABLE 56 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 57 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 7.2.2 EXTERNAL DEFIBRILLATORS
    • TABLE 58 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 59 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 60 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 61 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
      • 7.2.2.1 Automated external defibrillators
    • TABLE 62 INDICATIVE LIST OF AEDS THAT HAVE RECEIVED PREMARKET APPROVAL FROM THE FDA (2018-2019)
    • TABLE 63 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 64 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 65 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 66 AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
        • 7.2.2.1.1 Semi-automated external defibrillators
        • 7.2.2.1.1.1 Semi-automated external defibrillators accounted for the largest share of the AEDs market in 2018
        • 7.2.2.1.2 Fully automated external defibrillators
        • 7.2.2.1.2.1 Benefits of fully automatic AEDs and higher accuracy will drive market growth
      • 7.2.2.2 Manual external defibrillators
        • 7.2.2.2.1 North America dominates the manual defibrillators market
    • TABLE 67 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 68 MANUAL EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
      • 7.2.2.3 Wearable cardioverter defibrillators
        • 7.2.2.3.1 Ease of use and the noninvasive nature of wearable cardioverter defibrillators will support market growth
    • TABLE 69 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 70 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 7.3 PACEMAKERS
    • TABLE 71 PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 72 PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 7.3.1 PACEMAKERS MARKET, BY IMPLANTABILITY
    • TABLE 73 PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 74 PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
      • 7.3.1.1 Implantable pacemakers
        • 7.3.1.1.1 Introduction of leadless and MRI-safe devices has boosted device popularity
    • TABLE 75 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 76 IMPLANTABLE PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
      • 7.3.1.2 External pacemakers
        • 7.3.1.2.1 Increasing number of open-heart surgeries will drive the demand for external pacemakers
    • TABLE 77 EXTERNAL PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 78 EXTERNAL PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
    • 7.3.2 PACEMAKERS MARKET, BY TYPE
    • TABLE 79 PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 80 PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
      • 7.3.2.1 Dual-chamber pacemakers
        • 7.3.2.1.1 Dual-chamber pacemakers are the most commonly implanted pacemakers for bradycardia
    • TABLE 81 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 82 DUAL-CHAMBER PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
      • 7.3.2.2 Single-chamber pacemakers
        • 7.3.2.2.1 Introduction of leadless pacemakers will stimulate demand in this product segment
    • TABLE 83 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 84 SINGLE-CHAMBER PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
      • 7.3.2.3 Biventricular/CRT pacemakers
        • 7.3.2.3.1 High cost and unfavorable reimbursement scenario have hindered market growth
    • TABLE 85 BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 86 BIVENTRICULAR/CRT PACEMAKERS MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 7.4 COVID-19 IMPACT ANALYSIS

8 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 87 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 88 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 GROWING NUMBER OF CARDIAC IMPLANT PROCEDURES TO DRIVE MARKET GROWTH
    • TABLE 89 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 90 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR HOSPITALS, BY REGION, 2020-2025 (USD MILLION)
  • 8.3 CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS
    • 8.3.1 GROWING FOCUS ON AMBULATORY CARE IN THE US TO DRIVE THE ADOPTION OF CM & CRM DEVICES
    • TABLE 91 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 92 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR CLINICS, CARDIAC CENTERS, AND AMBULATORY SURGERY CENTERS, BY REGION, 2020-2025 (USD MILLION)
  • 8.4 OTHER END USERS
    • TABLE 93 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 94 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET FOR OTHER END USERS, BY REGION, 2020-2025 (USD MILLION)
  • 8.5 COVID-19 IMPACT ANALYSIS

9 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 95 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 96 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 97 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 98 CARDIAC MONITORING DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
    • TABLE 99 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2016-2019 (USD MILLION)
    • TABLE 100 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY REGION, 2020-2025 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 20 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
    • TABLE 101 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 102 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 103 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 104 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 105 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 106 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 107 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 108 NORTH AMERICA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 109 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 110 NORTH AMERICA: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 111 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 112 NORTH AMERICA: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 113 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 114 NORTH AMERICA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 115 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 116 NORTH AMERICA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 117 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 118 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 119 NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 120 NORTH AMERICA: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 121 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 122 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 123 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 124 NORTH AMERICA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 125 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 126 NORTH AMERICA: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 127 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 128 NORTH AMERICA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 Growing number of FDA approvals for CM & CRM devices to support market growth in the US
    • TABLE 129 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 130 US: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 131 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 132 US: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 133 US: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 134 US: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 135 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 136 US: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 137 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 138 US: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Growing focus of government and private organizations on providing funding for research to drive market growth
    • TABLE 139 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 140 CANADA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 141 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 142 CANADA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 143 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 144 CANADA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 145 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 146 CANADA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 147 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 148 CANADA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION) 138
  • 9.3 EUROPE
    • TABLE 149 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 150 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 151 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 152 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 153 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 154 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 155 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 156 EUROPE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 157 EUROPE: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 158 EUROPE: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 159 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 160 EUROPE: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 161 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 162 EUROPE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 163 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 164 EUROPE: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 165 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 166 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 167 EUROPE: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 168 EUROPE: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 169 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 170 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 171 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 172 EUROPE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 173 EUROPE: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 174 EUROPE: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 175 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 176 EUROPE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing healthcare expenditure to drive market growth
    • TABLE 177 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 178 GERMANY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 179 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 180 GERMANY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 181 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 182 GERMANY: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 183 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 184 GERMANY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 185 GERMANY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 186 GERMANY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 Rising prevalence of heart failure to drive the adoption of CRT devices in France
    • FIGURE 21 FRANCE: CRM DEVICE IMPLANTATION, 2015-2018
    • TABLE 187 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 188 FRANCE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 189 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 190 FRANCE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 191 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 192 FRANCE: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 193 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 194 FRANCE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 195 FRANCE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 196 FRANCE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Rising demand for home-based cardiac monitoring devices to support market growth
    • TABLE 197 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 198 UK: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 199 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 200 UK: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 201 UK: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 202 UK: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 203 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 204 UK: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 205 UK: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 206 UK: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Increasing incidence of atrial fibrillation among the elderly will drive market growth in Italy
    • TABLE 207 ITALY: NUMBER OF ELDERLY CITIZENS WITH ATRIAL FIBRILLATION (THOUSANDS)
    • TABLE 208 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 209 ITALY: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 210 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 211 ITALY: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 212 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 213 ITALY: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 214 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 215 ITALY: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 216 ITALY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 217 ITALY: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising awareness and growing device adoption indicate strong growth in the coming years
    • TABLE 218 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 219 SPAIN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 220 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 221 SPAIN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 222 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 223 SPAIN: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 224 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 225 SPAIN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 226 SPAIN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 227 SPAIN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 228 PERCENTAGE OF POPULATION AGED 60 YEARS OR OVER, 2017 VS. 2050
    • TABLE 229 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 230 ROE: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 231 ROE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 232 ROE: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 233 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 234 ROE: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 235 ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 236 ROE: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 237 ROE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 238 ROE: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 22 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SNAPSHOT
    • TABLE 239 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 240 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 241 APAC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 242 APAC: CARDIAC MONITORING DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 243 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2016-2019 (USD MILLION)
    • TABLE 244 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020-2025 (USD MILLION)
    • TABLE 245 APAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 246 APAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 247 APAC: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 248 APAC: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 249 APAC: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 250 APAC: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 251 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 252 APAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 253 APAC: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 254 APAC: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 255 APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 256 APAC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 257 APAC: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 258 APAC: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 259 APAC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 260 APAC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 261 APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 262 APAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 263 APAC: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 264 APAC: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 265 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 266 APAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 High healthcare expenditure and favorable reimbursement and insurance coverage to support market growth in Japan
    • FIGURE 23 JAPAN: HEALTH EXPENDITURE AS A SHARE OF GDP, 2005-2017
    • TABLE 267 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 268 JAPAN: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 269 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 270 JAPAN: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 271 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 272 JAPAN: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 273 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 274 JAPAN: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 275 JAPAN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 276 JAPAN: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Rising prevalence of CVDs and government support for infrastructural improvements will drive market growth
    • TABLE 277 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 278 CHINA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 279 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 280 CHINA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 281 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 282 CHINA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 283 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 284 CHINA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 285 CHINA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 286 CHINA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Government initiatives will propel market growth in India
    • TABLE 287 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 288 INDIA: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 289 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 290 INDIA: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 291 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 292 INDIA: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 293 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 294 INDIA: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 295 INDIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 296 INDIA: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 297 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 298 ROAPAC: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 299 ROAPAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 300 ROAPAC: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 301 ROAPAC: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 302 ROAPAC: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 303 ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 304 ROAPAC: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 305 ROAPAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 306 ROAPAC: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • TABLE 307 ROW: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 308 ROW: CARDIAC MONITORING DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 309 ROW: ECG DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 310 ROW: ECG DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 311 ROW: EVENT MONITORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 312 ROW: EVENT MONITORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 313 ROW: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 314 ROW: CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 315 ROW: DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 316 ROW: DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 317 ROW: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 318 ROW: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 319 ROW: T-ICDS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 320 ROW: T-ICDS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 321 ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 322 ROW: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 323 ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2016-2019 (USD MILLION)
    • TABLE 324 ROW: PACEMAKERS MARKET, BY IMPLANTABILITY, 2020-2025 (USD MILLION)
    • TABLE 325 ROW: PACEMAKERS MARKET, BY TYPE, 2016-2019 (USD MILLION)
    • TABLE 326 ROW: PACEMAKERS MARKET, BY TYPE, 2020-2025 (USD MILLION)
    • TABLE 327 ROW: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2016-2019 (USD MILLION)
    • TABLE 328 ROW: CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY END USER, 2020-2025 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
    • FIGURE 24 KEY DEVELOPMENTS IN THE CM & CRM DEVICES MARKET, JANUARY 2017-JULY 2020
    • FIGURE 25 MARKET EVOLUTION FRAMEWORK: JANUARY 2017 TO JULY 2020
  • 10.2 COMPETITIVE SCENARIO
    • 10.2.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 329 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2017-JULY 2020
    • 10.2.2 AGREEMENTS, CONTRACTS, COLLABORATIONS, AND PARTNERSHIPS
    • TABLE 330 KEY AGREEMENTS, CONTRACTS, COLLABORATIONS, AND PARTNERSHIPS, JANUARY 2017-JULY 2020
    • 10.2.3 ACQUISITIONS
    • TABLE 331 KEY ACQUISITIONS, JANUARY 2017-JULY 2020
    • 10.2.4 EXPANSIONS
    • TABLE 332 KEY EXPANSIONS, JANUARY 2017-JULY 2020

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

  • 11.1 COMPANY EVALUATION MATRIX DEFINITION AND METHODOLOGY
    • 11.1.1 MARKET SHARE ANALYSIS, 2019
    • FIGURE 26 CARDIAC MONITORING AND CARDIAC RHYTHM MANAGEMENT DEVICES MARKET SHARE ANALYSIS, 2019
  • 11.2 COMPANY EVALUATION MATRIX
    • 11.2.1 STARS
    • 11.2.2 EMERGING LEADERS
    • 11.2.3 PERVASIVE
    • 11.2.4 PARTICIPANTS
    • FIGURE 27 VENDOR DIVE: CM & CRM DEVICES MARKET
  • 11.3 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
    • 11.3.1 PROGRESSIVE COMPANIES
    • 11.3.2 STARTING BLOCKS
    • 11.3.3 RESPONSIVE COMPANIES
    • 11.3.4 DYNAMIC COMPANIES
    • FIGURE 28 VENDOR DIVE MATRIX FOR START-UPS: CM & CRM DEVICES MARKET
  • 11.4 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)**

    • 11.4.1 ABBOTT LABORATORIES
    • FIGURE 29 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)
    • 11.4.2 MEDTRONIC PLC
    • FIGURE 30 MEDTRONIC PLC: COMPANY SNAPSHOT (2019)
    • 11.4.3 BOSTON SCIENTIFIC CORPORATION
    • FIGURE 31 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.4.4 GE HEALTHCARE
    • FIGURE 32 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
    • 11.4.5 KONINKLIJKE PHILIPS N.V.
    • FIGURE 33 PHILIPS: COMPANY SNAPSHOT (2019)
    • 11.4.6 BIOTRONIK
    • 11.4.7 ASAHI KASEI CORPORATION
    • FIGURE 34 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.4.8 MICROPORT SCIENTIFIC CORPORATION
    • FIGURE 35 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.4.9 HILL-ROM HOLDINGS, INC.
    • FIGURE 36 HILL-ROM HOLDINGS: COMPANY SNAPSHOT (2019)
    • 11.4.10 NIHON KOHDEN CORPORATION
    • FIGURE 37 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2019)
    • 11.4.11 SCHILLER AG
    • 11.4.12 BIOTELEMETRY
    • FIGURE 38 BIOTELEMETRY: COMPANY SNAPSHOT (2019)
    • 11.4.13 ACS DIAGNOSTICS
    • 11.4.14 BPL MEDICAL TECHNOLOGIES
    • 11.4.15 BTL
    • 11.4.16 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
    • 11.4.17 LEPU MEDICAL TECHNOLOGY
    • FIGURE 39 LEPU MEDICAL TECHNOLOGY: COMPANY SNAPSHOT (2016)
    • 11.4.18 SHREE PACETRONIX
    • FIGURE 40 SHREE PACETRONIX: COMPANY SNAPSHOT (2017)
    • 11.4.19 OSYPKA AG
    • 11.4.20 ALIVECOR, INC.
    • 11.4.21 AMIITALIA
    • 11.4.22 BEXEN CARDIO
    • 11.4.23 NARANG MEDICAL LIMITED
    • 11.4.24 METRAX GMBH
    • 11.4.25 PROGETTI SRL

*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

12 ADJACENT MARKETS

  • 12.1 INTRODUCTION
  • 12.2 RESUSCITATION DEVICES MARKET
    • 12.2.1 MARKET DEFINITION
    • 12.2.2 MARKET OVERVIEW
      • 12.2.2.1 Driver: High demand for emergency care
  • 12.3 RESUSCITATION DEVICES MARKET, BY PRODUCT
    • TABLE 333 RESUSCITATION DEVICES MARKET, BY PRODUCT, 2018-2025 (USD MILLION)
  • 12.4 RESUSCITATION DEVICES MARKET, BY PATIENT TYPE
    • TABLE 334 RESUSCITATION DEVICES MARKET, BY PATIENT TYPE, 2018-2025 (USD MILLION)
  • 12.5 RESUSCITATION DEVICES MARKET, BY END USER
    • TABLE 335 RESUSCITATION DEVICES MARKET, BY END USER, 2018-2025 (USD MILLION)
  • 12.6 RESUSCITATION DEVICES MARKET, BY REGION
    • TABLE 336 RESUSCITATION DEVICES MARKET, BY REGION, 2018-2025 (USD MILLION)

13 APPENDIX

  • 13.1 INDUSTRY INSIGHTS
  • 13.2 DISCUSSION GUIDE
  • 13.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4 AVAILABLE CUSTOMIZATIONS
  • 13.5 RELATED REPORTS
  • 13.6 AUTHOR DETAILS 266
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.